Company intelligence / Profile preview

CannaMore

Frankfurt am Main, Hesse, Germany

Ownership: Private
Development stage: Other

Overview

CannaMore is a specialized German pharmaceutical company focused on the medical cannabis sector. Based in Frankfurt am Main, the company operates as a licensed wholesaler and importer of cannabinoid-based medicines. CannaMore provides a range of pharmaceutical-grade cannabis products, including dried flowers and extracts, to pharmacies and medical institutions across Germany. By maintaining strict quality standards and a robust distribution network, the company aims to facilitate reliable patient access to medical cannabis for various therapeutic indications. Their business model centers on bridging the gap between international producers and the German healthcare market through GDP-compliant logistics.

Therapeutic areas: PsychiatryNeurologyGastroenterology
Modalities: Small moleculePlant-based medicine
Industry: Biotech

Beyond the preview

Go deeper on CannaMore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CannaMore.

Explore the full profile